On Tuesday, Sysorex Global Holdings Corp (NASDAQ:SYRX)’s shares declined -2.95% to $2.30, as Big data software solutions and infrastructure provider Sysorex, declared that its Lilien Systems partner, has once again been named to The Channel Corporation’s CRN® Tech Elite 250. This annual list recognizes an elite group of IT solution providers that have invested in the training and education needed to earn the most advanced technical certifications from leading vendors. This is the third time that Lilien Systems has been named to the Tech Elite list.
Sysorex Global Holdings Corp., through its auxiliaries, provides data analytics and location based solutions and services to commercial and government customers worldwide. It operates through four segments: IT Commercial, IT Government, eSolutions, and Location-Based Technology.
Brocade Communications Systems, Inc. (NASDAQ:BRCD)’s shares dropped -2.95% to $11.84, during the last trading session on Tuesday, as Brocade, declared that CoxHealth, one of U.S. News’ Best Regional Hospitals, has selected Brocade® networking equipment and services to provide its five hospitals and 83 clinics with a highly reliable IT network infrastructure that improves patient care — recently, and into the era of the New IP.
With the aim of shifting from a flat, unreliable Layer 2 network built on disparate vendor solutions, the Springfield, Missouri-based healthcare provider required a networking solution that could be deployed across the Wide Area Network (WAN). This meant a solution spanning from the core, aggregation, and edge layers all the way to the Storage Area Network (SAN) in the data center, with simplified administration throughout.
Brocade Communications Systems, Inc. provides storage area networking (SAN) and Internet protocol networking solutions for businesses and organizations worldwide. It operates through SAN Products, IP Networking Products, and Global Services segments.
At the end of Tuesday’s trade, Horizon Pharma PLC (NASDAQ:HZNP)‘s shares dipped -2.95% to $27.65, as Horizon Pharma, declared that it is offering to sell 12,000,000 of its ordinary shares in an underwritten public offering. Horizon Pharma plc also anticipates to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the ordinary shares in the public offering.
Horizon Pharma plc, a specialty biopharmaceutical corporation, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
United Microelectronics Corp (ADR) (NYSE:UMC), ended its Tuesday’s trading session with -2.92% loss, and closed at $2.33, as United Microelectronics Corp, disclosed the availability of a complete set of low power consumption fundamental IPs developed for UMC’s 55nm Low Power (LP) embedded Flash process. These IPs are designed to simultaneously meet both low-power and high-density requirements to satisfy the demands of a broad range of applications including IoT (Internet of Things) and wearable products.
United Microelectronics Corporation provides semiconductor wafer foundry solutions. Its foundry solutions include silicon verification, libraries and IP, design verification, design for manufacturing, MM/RF foundry design kit and design support manual, and design flow reference, as well as mask services, such as mask inspection, IP protection and data preparation, and tape-out status tracking.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
